- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
April 14, 2014 (Reuters) — Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes reduced the use of insulin at meal times in a mid-stage study of patients with type 1 diabetes, sending the company's shares up as much as 17 percent.
Lexicon said the drug, codenamed LX4211, reduced the total dose of insulin taken by patients at meal times by 32 percent, compared with a 6 percent reduction in patien
April 14, 2014 (HealthDay News) — Research conducted on climbers atop Mount Everest offers new insight into the biological triggers for type 2 diabetes.
Specifically, the British investigators learned more about how low oxygen levels in the body (hypoxia) may be linked with insulin resistance, a risk factor for diabetes. Insulin resistance occurs when cells in the body fail to respond to insul
April 7, 2014 (Medical Xpress) --
Gastric banding can play a vital role in the treatment of type 2 diabetes in people who are overweight and not obese, according to new research.
February 26, 2013 (HealthDay News) -- There's no firm evidence that the type 2 diabetes medications known as incretin-based drugs cause pancreatitis or pancreatic cancer, U.S. and European health officials say.
But it's too early to say there's definitely no link between the injectable drugs and pancreatitis or pancreatic cancer, according to the s
February 12, 2014 (HealthDay News) -- Although it's a common belief that a diagnosis of type 2 diabetes often follows a large weight gain, a new study challenges that notion.
Researchers found that the majority of people diagnosed with type 2 diabetes didn't get the disease until they'd been overweight or obese for a number of years.
What's more, participants who maintained stable levels of overweight and eventually developed type 2 diabetes didn't have a significant rise in their l